BR0307721A - Processo para preparação de derivados de indolinona - Google Patents

Processo para preparação de derivados de indolinona

Info

Publication number
BR0307721A
BR0307721A BR0307721-7A BR0307721A BR0307721A BR 0307721 A BR0307721 A BR 0307721A BR 0307721 A BR0307721 A BR 0307721A BR 0307721 A BR0307721 A BR 0307721A
Authority
BR
Brazil
Prior art keywords
indolinone derivatives
preparing
preparing indolinone
derivatives
intermediates
Prior art date
Application number
BR0307721-7A
Other languages
English (en)
Inventor
Qingwu Jin
Michael A Mauragis
Paul D May
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/004407 external-priority patent/WO2002066463A1/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR0307721A publication Critical patent/BR0307721A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

"PROCESSO PARA PREPARAçãO DE DERIVADOS DE INDOLINONA". A presente invenção refere-se a um processo para preparação de derivados de indolinona da fórmula geral (VI) como definida no relatório descritivo e intermediários daquele processo.
BR0307721-7A 2002-02-15 2003-02-14 Processo para preparação de derivados de indolinona BR0307721A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2002/004407 WO2002066463A1 (en) 2001-02-15 2002-02-15 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
US41173202P 2002-09-18 2002-09-18
PCT/US2003/004520 WO2003070725A2 (en) 2002-02-15 2003-02-14 Process for preparing indolinone derivatives

Publications (1)

Publication Number Publication Date
BR0307721A true BR0307721A (pt) 2005-01-25

Family

ID=33029733

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307721-7A BR0307721A (pt) 2002-02-15 2003-02-14 Processo para preparação de derivados de indolinona

Country Status (16)

Country Link
US (2) US7119209B2 (pt)
EP (1) EP1476443A2 (pt)
JP (1) JP2005528344A (pt)
KR (1) KR100657110B1 (pt)
CN (1) CN1308326C (pt)
AR (1) AR041247A1 (pt)
AU (1) AU2003216282A1 (pt)
BR (1) BR0307721A (pt)
CA (1) CA2475455A1 (pt)
HK (1) HK1078075A1 (pt)
MX (1) MXPA04006992A (pt)
PL (1) PL372302A1 (pt)
RS (1) RS70904A (pt)
RU (1) RU2299209C2 (pt)
TW (1) TWI289560B (pt)
WO (1) WO2003070725A2 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
EP1476443A2 (en) * 2002-02-15 2004-11-17 PHARMACIA & UPJOHN COMPANY Process for preparing indolinone derivatives
US7452913B2 (en) * 2003-02-24 2008-11-18 Pharmacia & Upjohn Company Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
WO2005023765A1 (en) * 2003-09-11 2005-03-17 Pharmacia & Upjohn Company Llc Method for catalyzing amidation reactions by the presence of co2
BRPI0415022A (pt) * 2003-10-02 2006-11-28 Pharmacia & Upjohn Co Llc sais e polimorfos de um composto de indolinona substituìda com pirrol
US20060009510A1 (en) * 2004-07-09 2006-01-12 Pharmacia & Upjohn Company Llc Method of synthesizing indolinone compounds
US20100267719A1 (en) * 2005-05-26 2010-10-21 The Scripps Research Institute Enhanced Indolinone Based Protein Kinase Inhibitors
ES2328407T3 (es) 2005-09-19 2009-11-12 Pfizer Products Incorporated Formas salinas solidas de una 2-indolinona sustituida con pirrol.
US20090004213A1 (en) 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
US20100256392A1 (en) * 2007-11-21 2010-10-07 Teva Pharmaceutical Industries Ltd. Polymorphs of sunitinib base and processes for preparation thereof
WO2009067686A2 (en) * 2007-11-21 2009-05-28 Teva Pharmaceutical Industries Ltd. Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
EP2098521A1 (en) * 2008-03-06 2009-09-09 Ratiopharm GmbH Crystal forms of N-[2-(diethylamino) ethyl]-5-[fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrolle-3-carboxamide and methods for their prepparation
WO2009124037A1 (en) * 2008-03-31 2009-10-08 Teva Pharmaceutical Industries Ltd. Processes for preparing sunitinib and salts thereof
US8466190B2 (en) 2008-04-16 2013-06-18 Natco Pharma Limited Polymorphic forms of Sunitinib base
WO2009157011A1 (en) 2008-06-23 2009-12-30 Natco Pharma Limited Process for the preparation of high purity sunitinib and its pharmaceutically acceptable salt
WO2009156837A2 (en) * 2008-06-26 2009-12-30 Medichem, S.A. Amorphous form of a 3-pyrrole substituted 2-indolinone malate salt
WO2010011834A2 (en) 2008-07-24 2010-01-28 Teva Pharmaceutical Industries Ltd. Sunitinib and salts thereof and their polymorphs
EP2318393A1 (en) * 2008-08-25 2011-05-11 Generics [UK] Limited Novel polymorphs of sunitinib and processes for their preparation
JP2012500837A (ja) * 2008-08-25 2012-01-12 ジェネリクス・（ユーケー）・リミテッド 新規な結晶型およびその調製方法
WO2011004200A1 (en) 2009-07-10 2011-01-13 Generics [Uk] Limited Novel pyrrole derivatives
WO2011104555A2 (en) 2010-02-25 2011-09-01 Generics [Uk] Limited Novel process
EP2545034A1 (en) 2010-03-10 2013-01-16 Synthon B.V. A process for amidation of pyrrole carboxylate compounds
WO2011128699A2 (en) 2010-04-16 2011-10-20 Generics [Uk] Limited Novel process
WO2012042421A1 (en) 2010-09-29 2012-04-05 Pfizer Inc. Method of treating abnormal cell growth
EP2635568B1 (en) 2010-11-01 2017-08-16 Scinopharm (Kunshan) Biochemical Technology Co., Ltd. Processes for the preparation of 3-(pyrrol-2-yl)methylene)-2-pyrrolones using 2-silyloxy-pyrroles
WO2012139019A2 (en) * 2011-04-08 2012-10-11 Beta Pharma, Inc. New indolinone protein kinase inhibitors
SG10201603896RA (en) 2012-05-04 2016-07-28 Pfizer Prostate-associated antigens and vaccine-based immunotherapy regimens
HUE043042T2 (hu) 2013-11-01 2019-07-29 Pfizer Vektorok prosztatához kapcsolódó antigének expressziójára
CN104744442B (zh) * 2013-12-25 2019-05-28 江苏豪森药业集团有限公司 苹果酸舒尼替尼的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316635B1 (en) 1995-06-07 2001-11-13 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
WO1998038984A2 (en) 1997-03-05 1998-09-11 Sugen, Inc. Formulations for hydrophobic pharmaceutical agents
US6316429B1 (en) 1997-05-07 2001-11-13 Sugen, Inc. Bicyclic protein kinase inhibitors
US6133305A (en) 1997-09-26 2000-10-17 Sugen, Inc. 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
JP2002507598A (ja) 1998-03-26 2002-03-12 スージェン・インコーポレーテッド チロシン蛋白質キナーゼを調節するためのヘテロ環式化合物のファミリー
PT1255536E (pt) 1999-12-22 2006-09-29 Sugen Inc Derivados de indolinona para a modulacao da tirosina proteina cinase de tipo c-kit
ATE369359T1 (de) * 2000-02-15 2007-08-15 Sugen Inc Pyrrol substituierte indolin-2-on protein kinase inhibitoren
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
TWI259081B (en) 2001-10-26 2006-08-01 Sugen Inc Treatment of acute myeloid leukemia with indolinone compounds
EP1476443A2 (en) * 2002-02-15 2004-11-17 PHARMACIA & UPJOHN COMPANY Process for preparing indolinone derivatives

Also Published As

Publication number Publication date
US20030229229A1 (en) 2003-12-11
MXPA04006992A (es) 2004-11-10
KR20040081203A (ko) 2004-09-20
TWI289560B (en) 2007-11-11
KR100657110B1 (ko) 2006-12-12
RS70904A (en) 2006-10-27
JP2005528344A (ja) 2005-09-22
RU2004124711A (ru) 2006-01-20
CN1671693A (zh) 2005-09-21
HK1078075A1 (en) 2006-03-03
AU2003216282A1 (en) 2003-09-09
CA2475455A1 (en) 2003-08-28
WO2003070725A2 (en) 2003-08-28
US7119209B2 (en) 2006-10-10
TW200410958A (en) 2004-07-01
PL372302A1 (en) 2005-07-11
US20050171357A1 (en) 2005-08-04
EP1476443A2 (en) 2004-11-17
CN1308326C (zh) 2007-04-04
RU2299209C2 (ru) 2007-05-20
AR041247A1 (es) 2005-05-11
WO2003070725A3 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
BR0307721A (pt) Processo para preparação de derivados de indolinona
BR0307529A (pt) Derivados de n-fenil-2-pirimidina-amina
BR0312729A (pt) Novos derivados de indol-3-enxofre
BRPI0408369A (pt) derivados de indol úteis para o tratamento de doenças
BR0308967A (pt) Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação
BRPI0518601A2 (pt) processo para preparaÇço de derivados de piperazin-2-ona anelados bem como produtos intermediÁrios do processo
BR0311494A (pt) Novos indóis substituìdos
BRPI0407967A (pt) processo de uma etapa para a preparação de derivados anticonvulsivantes
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
BRPI0511956A (pt) processo para a preparação dos compostos, e, intermediários de sìntese
TW200716152A (en) Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
BRPI0414436A (pt) processo para a preparação de derivados de 2-oxo-1-pirrolidina e seus sais
BRPI0517390A (pt) processo para a preparação de derivados de [1,4,5]-oxadiazepina
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
BR0208534A (pt) Processo para preparação de 4,6-diaminopirimido[5,4-d]pirimidinas
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
BR0314195A (pt) Derivados de piridina substituìda como agentes antitumorais
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
BRPI0411209A (pt) uso de derivados isoindolinona como inseticidas
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
EA200701852A1 (ru) Производные аминокислот

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.